TUCSON, Ariz., Nov. 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the signing of a collaboration and ...

See accompanying notes to consolidated financial statements. View original content to download multimedia:https://www.prnewswire.com/news-releases/accelerate ...

Accelerate Diagnostics, Inc. AXDX has secured FDA 510(k) clearance for its Accelerate Arc system and BC kit, designed for use with Bruker's MALDI Biotyper CA system (MBT-CA System) and MBT-CA ...

Accelerate Diagnostics (AXDX) is an in vitro diagnostics company that has developed the Accelerate Pheno system and accompanying PhenoTest BC kit, which provides rapid Identification ("ID") and ...

TUCSON, Ariz., March 21, 2025 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX), an innovator in rapid in vitro diagnostics for microbiology, today announced the submission of its Accelerate ...

Preliminary data indicate the rate of sepsis mortality related to overall patient deaths is dropping at University Health Care System in Augusta, Ga. So what are they doing differently? Accelerate ...

Investors were encouraged by a recent award the company received in the effort to diagnose and treat sepsis more rapidly. Sepsis is a potentially fatal response from the body to an infection, and 1.7 ...

Accelerate Diagnostics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Accelerate ...

Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.14. Operator: Good day, and welcome to the Accelerate Diagnostics Incorporated 2023 Q1 ...